North Brunswick, N.J. – October 30, 2026 -- All five antibody-deficient mice treated with Lactiga's LCTG-001 survived influenza infection, compared with two of five in the control group, according to a peer-reviewed preclinical study conducted by McMaster University scientists in collaboration with Lactiga US, Inc.

TAMPA – – October 27, 2026 -- Akari Therapeutics (Nasdaq: AKTX) reported that its TROP2-targeted ADC AKTX-101 slowed tumor growth in urothelial cancer models with limited response to Padcev or acquired resistance to Trodelvy. The company is targeting a Phase 1 start in mid-2027.

Perth – October 14, 2026 -- Sun Silver Limited (ASX: SS1; OTCQX: SSLVF) recovered 84.5% of silver and 83.6% of gold within 24 hours in cyanide leach testwork on its Maverick Silver Project in Nevada, strengthening the case for a tank-leach/CIL processing route alongside heap leach.

Indianapolis – October 14, 2026 -- Carnyx Therapeutics Ltd. unveiled CNYX-005, an oral sleep candidate that increased total sleep time by roughly 1.5 to 2 hours in aged rats versus a control arm, as the preclinical-stage company moves toward clinical development.

The increase was driven primarily by more non-rapid eye movement (NREM) sleep. Researchers measured sleep architecture using continuous electroencephalography (EEG) monitoring.

Los Angeles – October 12, 2026 -- TED patients with pre-existing hearing loss were more than 60% less likely to suffer a further hearing decline when teprotumumab (TEPEZZA) infusions were spaced six weeks apart instead of the standard three, according to a retrospective study presented at the ASOPRS 57th Annual Fall Scientific Symposium.